(Q38151571)

29 August 2017

title

Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics (English)

1 reference

29 August 2017

1 reference

Seigo Sanoh

1

1 reference

29 August 2017

Shigeru Ohta

series ordinal

2

1 reference

29 August 2017

publication date

29 October 2013

1 reference

Biopharmaceutics and Drug Disposition

29 August 2017

published in

1 reference

29 August 2017

volume

35

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

71-86

1 reference

Can the pharmaceutical industry reduce attrition rates?

29 August 2017

cites work

1 reference

Trial watch: Phase II failures: 2008-2010.

21 January 2018

1 reference

The role of non-P450 enzymes in drug oxidation

21 January 2018

1 reference

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

21 January 2018

1 reference

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

21 January 2018

1 reference

Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites

21 January 2018

1 reference

Comparison of oral absorption and bioavailablity of drugs between monkey and human

21 January 2018

1 reference

Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.

21 January 2018

1 reference

Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance

21 January 2018

1 reference

Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.

21 January 2018

1 reference

Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance

21 January 2018

1 reference

Prediction of hepatic clearance in human from in vitro data for successful drug development

21 January 2018

1 reference

Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.

21 January 2018

1 reference

Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research

21 January 2018

1 reference

Prediction of the in vitro intrinsic clearance determined in suspensions of human hepatocytes by using artificial neural networks.

21 January 2018

1 reference

Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance

21 January 2018

1 reference

Near completely humanized liver in mice shows human-type metabolic responses to drugs

21 January 2018

1 reference

The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.

21 January 2018

1 reference

Expression of human cytochromes P450 in chimeric mice with humanized liver.

21 January 2018

1 reference

Expression of human phase II enzymes in chimeric mice with humanized liver

21 January 2018

1 reference

Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver.

21 January 2018

1 reference

Application of chimeric mice with humanized liver for predictive ADME.

21 January 2018

1 reference

Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver

21 January 2018

1 reference

In vitro evaluation of cytochrome P450 and glucuronidation activities in hepatocytes isolated from liver-humanized mice

21 January 2018

1 reference

Humanization of excretory pathway in chimeric mice with humanized liver.

21 January 2018

1 reference

In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver.

21 January 2018

1 reference

Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver

21 January 2018

1 reference

In vivo drug interactions of the teratogen thalidomide with midazolam: heterotropic cooperativity of human cytochrome P450 in humanized TK-NOG mice.

21 January 2018

1 reference

CYP2C9-catalyzed metabolism of S-warfarin to 7-hydroxywarfarin in vivo and in vitro in chimeric mice with humanized liver

21 January 2018

1 reference

Prediction of human disposition toward S-3H-warfarin using chimeric mice with humanized liver.

21 January 2018

1 reference

Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers

21 January 2018

1 reference

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

Mechanisms of troglitazone hepatotoxicity

21 January 2018

1 reference

Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers

21 January 2018

1 reference

Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolites.

21 January 2018

1 reference

Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury.

21 January 2018

1 reference

uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study.

21 January 2018

1 reference

Assessment of chimeric mice with humanized liver as a tool for predicting circulating human metabolites.

21 January 2018

1 reference

Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor

21 January 2018

1 reference

In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.

21 January 2018

1 reference

Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice

21 January 2018

1 reference

Approach for in vivo protein binding of 5-n-butyl-pyrazolo[1,5-a]pyrimidine bioactivated in chimeric mice with humanized liver by two-dimensional electrophoresis with accelerator mass spectrometry

21 January 2018

1 reference

Human cytochrome P450 1A2 involvement in the formation of reactive metabolites from a species-specific hepatotoxic pyrazolopyrimidine derivative, 5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimidine

21 January 2018

1 reference

Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes

21 January 2018

1 reference

Studies on the fate of naproxen. II. Metabolic fate in various animals and man

21 January 2018

1 reference

Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology

21 January 2018

1 reference

Increasing recognition of the importance of aldehyde oxidase in drug development and discovery

21 January 2018

1 reference

In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor

21 January 2018

1 reference

Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.

21 January 2018

1 reference

Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications

21 January 2018

1 reference

In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase

21 January 2018

1 reference

Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes

21 January 2018

1 reference

In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats.

21 January 2018

1 reference

Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats

21 January 2018

1 reference

Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase

21 January 2018

1 reference

Individual variation in hepatic aldehyde oxidase activity

21 January 2018

1 reference

The impact of single nucleotide polymorphisms on human aldehyde oxidase

21 January 2018

1 reference

Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver

21 January 2018

1 reference

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

21 January 2018

1 reference

Strategies for a comprehensive understanding of metabolism by aldehyde oxidase

21 January 2018

1 reference

Morphological and microarray analyses of human hepatocytes from xenogeneic host livers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.1864

1 reference

29 August 2017

1 reference